enGene Therapeutics Inc. Common Stock, Value, Issued
enGene Therapeutics Inc. (ENGN) had Common Stock, Value, Issued of $632.02 million as of 2026-07-31, per its 10-Q filed 2026-09-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-09-08
- 2026-07-31: Common Stock, Value, Issued $632.02M.
- 2026-04-30: Common Stock, Value, Issued $632.00M.
- 2026-01-31: Common Stock, Value, Issued $631.99M.
- 2025-10-31: Common Stock, Value, Issued $513.28M.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-07-31 | $632.02M 10-Q · filed 2026-09-08 |
| 2026-04-30 | $632.00M 10-Q · filed 2026-06-15 |
| 2026-01-31 | $631.99M 10-Q · filed 2026-03-09 |
| 2025-10-31 | $513.28M 10-Q · filed 2026-09-08 |
| 2025-07-31 | $510.16M 10-Q · filed 2025-09-11 |
| 2025-04-30 | $510.12M 10-Q · filed 2025-06-12 |
| 2025-01-31 | $509.81M 10-Q · filed 2025-03-10 |
| 2024-10-31 | $509.81M 10-K · filed 2025-12-22 |
| 2024-07-31 | $453.48M 10-Q · filed 2024-09-10 |
| 2024-04-30 | $453.40M 10-Q · filed 2024-06-14 |
| 2024-01-31 | $259.37M 10-Q · filed 2024-03-11 |
| 2023-10-31 | $259.37M 10-K · filed 2024-12-19 |
| 2022-10-31 | $16.39M 10-K · filed 2024-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |